Patients exposed to meningitis contained in an injectable painkiller already have sued the Massachusetts compounding pharmacy that mixed the drug, seeking millions of dollars in damages. But some plaintiffs are pursuing deeper pockets – including physicians and medical clinics – under a variety of legal theories. These plaintiffs claim that suppliers, distributors and healthcare providers in the chain of distribution are liable for patients’ injuries, regardless of whether they knew the product was defective.
Our publication reviews the case facts and how litigation targets have expanded to include healthcare providers. We also list practical steps that compounding pharmacies can take to prepare for anticipated heightened scrutiny of their operations.